Submitted 19 june 2022 accepted 18 oct 2022 published 16 jan 2023 corresponding author: curtiland deville jr, md department of radiation oncology and molecular radiation sciences johns hopkins university school of medicine 401 n broadway, weinberg suite 1440 baltimore, md 21231 phone: þ 1 (202) 537-4788 fax: 1 (202) 537-4964 cdeville@jhmi.edu original article

HIGHLIGHTS

  • who: Dose/fraction and collaborators from the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA Department of Oncology and Molecular Sciences, Johns Hopkins University School of have published the paper: Submitted 19 June 2022 Accepted 18 Oct 2022 Published 16 Jan 2023 Corresponding Author: Curtiland Deville Jr, MD Department of Radiation Oncology and Molecular Radiation Sciences Johns Hopkins University School of Medicine 401 N Broadway, Weinberg Suite 1440 Baltimore, MD 21231 Phone: u00fe 1 (202) 537-4788 Fax: 1 (202) 537-4964 cdeville, in the Journal: (JOURNAL) of 19/06/2022
  •  

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?